Experienced in providing strategic guidance and leadership support for biotech and cell & gene therapy organizations. Specializing in board membership, commercial strategic advising for biopharma CDMOs of multiple modalities, and consulting services for private equity firms.

Board Member until taking on permanent role with BioCina as Chief Commercial Officer

Leading Termumo BCT Cell Processing & Biologics business unit sales organization.

Responsible for leading global biologics/GPEx (Gene Product Expression) business development for development and manufacturing capabilities to biotechology and pharmaceutical organizations.

Crucell is a Dutch biotech company developing US based operations for licensing of protein and antibody production platform technology using a human cell line.Responsible for licensing strategy and negotiating corporate deals of Crucell's cell line technology with biotech firms throughout the US.

Manage Area Business Managers in Rocky Mountain Region, covering 17 states for biologic dermatology product. Manage region to growth of unit sales, key customer development and personal professional achievement. Coordinate Medical Science Liaisons and Business Relation Managers to assist sales team in achieving goals. Experience in ‘Buy and Bill’ model and managed care issues for physicians. Generated new strategies and tactics for region to implement.

Developed strategic commercialization and publication plan for new product with international indications in neurology and dermatology. Coordinated international launch plan to align with US goals. Worked with clinical, international medical and regulatory, manufacturing and commercial teams to ensure timelines were met and positioning was consistent worldwide. Critical issues included pricing, positioning, IP (patent protection) and market research. Conducted corporate symposium with international key opinion leaders to determine future opportunities. Involved in design of Phase II/III studies for indications multiple sclerosis.

Managed Medical/Physician marketing budget for Neurology business unit. Involved with Phase IV and Investigator Initiated Studies (IIS) planning and initiated new process to identify site selection. Developed strategic and tactical plan for promotion of treatment algorithm for multiple sclerosis therapy, including CME, medical education and publications and Phase IV studies. Completed partnership agreement with diagnostic company for strategic positioning. Developed marketing messages and plan for Sales Force and Medical Science Liaisons. Executed concise and consistent plans with CME and Medical Communications vendors. Worked on Publication Planning Committee with medical and legal staff to ensure timely scientific literature. Involved in due diligence evaluation of potential in-licensed product.